(Total Views: 161)
Posted On: 01/03/2019 3:51:38 PM
Post# of 103184
$BBT.C Benchmark Botanics chart looks extremely bearish. Which I believe is an excellent opportunity as an entry point in that the share price will rebound in 2019 to its MA (200) of $0.75 providing investors with significant gains.
Investment Highlights
Multi licensed producer, pharmaceutical, medicinal and recreational cannabis
Sales & revenues, growth with expansion
Expansion plans for large scale greenhouses, Pitt Meadows 5 acres 174,240 sq ft, Second Peachland facility 50,000 sq ft
Production capacity 15,550 kg /yr potential
Potential revenues estimated $77,750,000 / yr
Sales and distribution strategy for Europe
Pharmaceutical production and manufacturing vertical developed
Wholesale and retail sales Canada, & EU
Multiple products, flowers, oils, creams, capsules, beverages, nutraceuticals
Asia Pacific nutraceutical market potential
Investment Highlights
Multi licensed producer, pharmaceutical, medicinal and recreational cannabis
Sales & revenues, growth with expansion
Expansion plans for large scale greenhouses, Pitt Meadows 5 acres 174,240 sq ft, Second Peachland facility 50,000 sq ft
Production capacity 15,550 kg /yr potential
Potential revenues estimated $77,750,000 / yr
Sales and distribution strategy for Europe
Pharmaceutical production and manufacturing vertical developed
Wholesale and retail sales Canada, & EU
Multiple products, flowers, oils, creams, capsules, beverages, nutraceuticals
Asia Pacific nutraceutical market potential
(0)
(0)
